PEOPLE - Exagen Diagnostics makes appointment:
This article was originally published in Clinica
Executive Summary
Exagen Diagnostics (Albuquerque, New Mexico), a specialist in genomic marker-based IVD kits targeting treatment responses, has appointed Thomas Williams, a special advisor for molecular pathology, to chief scientific officer and vice-president for R&D. Dr Williams, who retains his post as part-time professor of pathology at the University of New Mexico, was formerly the department's vice-chairman, and director of New Mexico-based TriCore Reference Laboratories' genetics and cytometry division.
You may also be interested in...
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.